Double-blind Randomized Multi-center Trial Regarding the Effects of Solution for Gemcitabine on Frequency and Degree of Vascular Pain in Patients with Cancer
Not Applicable
Recruiting
- Conditions
- on-small-cell lung cancer, Bile duct cancer, Pancreatic cancer
- Registration Number
- JPRN-UMIN000001827
- Lead Sponsor
- Tohoku University Translational Research Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Not provided
Exclusion Criteria
(1) Without active interstitial pneumonitis or uncontrollable lung fibrosis (2) No concurrent thoracic radiotherapy during chemotherapy; (3) Without uncontrollable infectious disease; (4) No severe complication including heart failure, renal insufficiency, liver dysfunction, hemorrhagic digestive tract ulcer, ileus, and uncontrollable diabetic mellitus (5) Without pregnancy or nurse (6) No uncontrollable mental disease (7) No inappropriate patient judged by a medical doctor for enrollment into this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method